Bank Of America Corp Cabaletta Bio, Inc. Transaction History

Bank Of America Corp

$1.33 Trillion
Q2 2025

A detailed history of Bank Of America Corp transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 498,243 shares of CABA stock, worth $717,469. This represents 0.0% of its overall portfolio holdings.

Number of Shares

498,243

Previous 984,095 49.37%

Holding current value

$717,469

Previous $1.37 Million 44.62%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$1.04 - $2.48 $505,286 - $1.2 Million	-485,852 Reduced 49.37%	498,243 $757,000
Q1 2025 May 15, 2025	BUY	$1.39 - $2.74 $608,311 - $1.2 Million	437,634 Added 80.09%	984,095 $1.37 Million
Q4 2024 Feb 14, 2025	BUY	$1.87 - $4.91 $126,761 - $332,834	67,787 Added 14.16%	546,461 $1.2 Million
Q3 2024 Nov 14, 2024	BUY	$3.94 - $8.24 $1.22 Million - $2.55 Million	309,569 Added 183.06%	478,674 $2.26 Million
Q2 2024 Aug 14, 2024	SELL	$7.22 - $18.82 $498,165 - $1.3 Million	-68,998 Reduced 28.98%	169,105 $1.26 Million
Q1 2024 May 15, 2024	BUY	$16.79 - $25.38 $1.3 Million - $1.97 Million	77,583 Added 48.33%	238,103 $4.06 Million
Q4 2023 Feb 14, 2024	BUY	$12.21 - $23.36 $1.65 Million - $3.15 Million	135,022 Added 529.54%	160,520 $3.64 Million
Q2 2023 Aug 14, 2023	BUY	$7.65 - $13.95 $127,349 - $232,225	16,647 Added 188.08%	25,498 $329,000
Q1 2023 May 12, 2023	BUY	$7.08 - $12.62 $53,992 - $96,240	7,626 Added 622.53%	8,851 $73,000
Q4 2022 Feb 10, 2023	SELL	$0.64 - $9.3 $5,100 - $74,111	-7,969 Reduced 86.68%	1,225 $11,000
Q3 2022 Nov 14, 2022	SELL	$0.63 - $2.05 $3,813 - $12,408	-6,053 Reduced 39.7%	9,194 $6,000
Q2 2022 Aug 12, 2022	SELL	$0.99 - $2.11 $16,960 - $36,148	-17,132 Reduced 52.91%	15,247 $16,000
Q1 2022 May 16, 2022	BUY	$1.68 - $3.92 $42,450 - $99,050	25,268 Added 355.34%	32,379 $66,000
Q4 2021 Feb 08, 2022	SELL	$3.36 - $14.64 $24,850 - $108,277	-7,396 Reduced 50.98%	7,111 $27,000
Q3 2021 Nov 15, 2021	SELL	$7.0 - $12.5 $39,886 - $71,225	-5,698 Reduced 28.2%	14,507 $176,000
Q2 2021 Sep 13, 2021	BUY	$7.2 - $11.73 $145,476 - $237,004	20,205 New	20,205 $174,000

Others Institutions Holding CABA

# of Institutions

Shares Held

77.1M

Call Options Held

406K

Put Options Held

90.9K

View Full List

About Cabaletta Bio, Inc.

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $41.8M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

More about CABA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Cabaletta Bio, Inc. Transaction History